Clinical Trial Update: Unilateral Bevacizumab for Bilateral Diabetic Macular Edema [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating unilateral bevacizumab for bilateral diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 4 | Status: WITHDRAWN